Recombinant Chicken Golgi to ER traffic protein 4 homolog (GET4)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional fees.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The specific tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
GET4; RCJMB04_10o20; Golgi to ER traffic protein 4 homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-312
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gallus gallus (Chicken)
Target Names
GET4
Target Protein Sequence
MAAAIMAAEQ EAAKGGGRNR GGVQRVEGKL RASVEKGDYY EAHQMYRTLF FRYMSQGKYV EARELMYSGA LLFFSHNQQN SAADLSMLVL ESLEKSDAKV TDDLLENLAK LFSLMDPNSP ERVAFVSRAL KWSSGGSGKL GHPKLHQLLA ITLWKDGEGC ANMLVEYSSS RGYRSEVDMF VAQAVLQFLC LKNKTSASVV FTTYTQKHPS IEKGPPFVQP LLNFIWFLLL AVDGGKLTVF TVLCEQYQPS LKRDPMYNEY LDRIGQLFFG VPPKQTSSYG GLLGNLLNSL MGTGEDDDTE DGQEDSSPIE LD
Uniprot No.

Target Background

Function
The BAG6/BAT3 complex, of which this protein is a component, is a cytosolic protein quality control complex. It maintains misfolded and hydrophobic proteins in a soluble state, facilitating their delivery to the endoplasmic reticulum (ER) or targeting them to the proteasome for degradation. This complex is crucial for the post-translational delivery of tail-anchored/type II transmembrane proteins to the ER membrane. It interacts with the transmembrane region of newly synthesized tail-anchored proteins at the ribosome, mediating ER delivery in conjunction with SGTA and ASNA1. Proteins improperly delivered to the ER are ubiquitinated and proteasomally degraded. Similarly, the BAG6/BAT3 complex sorts mislocalized secretory pathway proteins, either directing them to the proteasome or the ER. It also plays a role in ER-associated degradation (ERAD), maintaining retrotranslocated proteins in a soluble state to ensure efficient proteasomal targeting.
Database Links
Protein Families
GET4 family
Subcellular Location
Cytoplasm, cytosol.

Q&A

What is GET4 and what are its primary functions in cellular biology?

GET4 (Golgi to ER traffic protein 4 homolog) is a protein originally identified in Saccharomyces cerevisiae with homologs present across various species including chickens. The protein functions primarily in the guided entry of tail-anchored proteins pathway, facilitating proper insertion of tail-anchored membrane proteins into the endoplasmic reticulum. GET4 exhibits key biochemical functions including chaperone binding and protein binding capabilities .

In the cellular context, GET4 serves as part of the transmembrane domain recognition complex (TRC), where it acts as a crucial adapter protein that bridges between the pretargeting and targeting complexes in the GET pathway. This system is essential for the proper localization of numerous membrane proteins that contain a single C-terminal transmembrane domain, ensuring their correct targeting to the endoplasmic reticulum membrane .

How does chicken GET4 differ structurally and functionally from its homologs in other species?

Chicken GET4 maintains the core functional domains present in mammalian homologs, but exhibits species-specific sequence variations that likely impact its binding affinity and interaction network. While the central α-helical structure remains conserved across species, chicken GET4 shows approximately 75-80% sequence identity with human GET4, with most divergence occurring in non-conserved loop regions.

What expression systems are commonly used for producing recombinant chicken GET4?

Multiple expression systems have been successfully employed for recombinant chicken GET4 production, each offering distinct advantages depending on research requirements. The most common systems include:

  • Mammalian cell expression systems: These provide the most native-like post-translational modifications and folding environments. HEK293 cells are particularly effective for chicken GET4 expression when proper protein folding is critical .

  • E. coli bacterial expression: This system offers high yield and cost-effectiveness, though it may lack some post-translational modifications. It's particularly suitable when large quantities of functional protein are needed for structural studies or antibody production .

  • In vitro cell-free systems: These provide rapid production capabilities and are especially useful for preliminary functional studies or when cellular toxicity is a concern .

The choice of expression system significantly impacts protein yield, folding, and functionality. For applications requiring authentic post-translational modifications, mammalian cell systems are preferable, while bacterial systems may be more appropriate for structural studies requiring larger protein quantities .

How can site-specific recombination techniques be optimized for studying GET4 function in chicken models?

Site-specific recombination for studying GET4 in chicken models can be optimized through a strategic implementation of Flipase (Flp)-mediated recombinase-mediated gene cassette exchange (RMCE). This approach begins with establishing transgenic chicken lines containing Flp recognition target (FRT) pairs in the genome via piggyBac transposition .

The optimization process requires several critical considerations:

  • FRT pair positioning: Strategic placement of FRT sites flanking the GET4 gene or regulatory elements is crucial. Integrated FRT pairs should be positioned to minimize disruption of native gene regulation while allowing controlled manipulation of GET4 .

  • Transgene integration assessment: Thorough characterization of integration patterns across different transgenic lines is essential, as integration diversity directly affects expression levels of exogenous genes. Southern blot analysis combined with quantitative PCR can verify both integration patterns and copy numbers .

  • Tissue-specific expression control: The methodological approach should incorporate tissue-specific promoters when studying GET4 function in particular cellular contexts. This allows for more precise analysis of GET4's role in specialized cellular environments without systemic disruption .

  • Temporal regulation: Implementing inducible systems (such as tetracycline-controlled transcriptional activation) alongside RMCE provides temporal control over gene expression, enabling studies of GET4 function during specific developmental windows or cellular states .

By incorporating these optimizations, researchers can achieve precise manipulation of GET4 expression in chicken models, facilitating detailed functional studies without confounding epigenetic influences .

What experimental design considerations are crucial when investigating GET4's interaction with protein binding partners?

When designing experiments to investigate GET4's protein interactions, several critical methodological considerations must be addressed:

  • Appropriate control selection: For valid interpretation of interaction data, both positive controls (known binding partners like UBL4A) and negative controls must be included. Non-interacting proteins with similar biochemical properties to GET4 serve as essential negative controls to establish specificity thresholds .

  • Variable manipulation strategy: Define independent variables (e.g., GET4 concentration, binding conditions) and dependent variables (interaction strength, binding kinetics) with precision. Consider possible confounding variables such as post-translational modifications or conformational states that may influence binding .

  • Methodological triangulation: Employ multiple complementary techniques to validate interactions:

    • Co-immunoprecipitation establishes physiologically relevant interactions

    • Yeast two-hybrid screening identifies novel interaction partners

    • Surface plasmon resonance provides quantitative binding kinetics

    • Proximity ligation assays confirm interactions in intact cellular contexts

  • Between-subjects vs. within-subjects design: When comparing GET4 from different species or mutant variants, determine whether a between-subjects design (different proteins tested separately) or within-subjects design (competitive binding assays) will provide more robust data. Between-subjects designs may require larger sample sizes but avoid competitive interference effects .

  • Statistical power planning: Calculate appropriate sample sizes needed to detect biologically meaningful differences in binding affinity. This typically requires preliminary data on binding variability and estimated effect sizes .

The experimental approach should also incorporate measurement validation steps, including verification of recombinant protein integrity and activity before interaction studies commence. This methodological framework ensures reliable identification and characterization of GET4's genuine biological interaction network .

How does post-translational modification affect recombinant chicken GET4 function and experimental outcomes?

Post-translational modifications (PTMs) significantly influence recombinant chicken GET4 function and can dramatically impact experimental outcomes. The selection of expression system directly determines the PTM profile, with mammalian cell systems providing more authentic modifications compared to bacterial expression systems .

Key methodological considerations for addressing PTM effects include:

  • PTM mapping strategy: Prior to functional studies, comprehensive mapping of PTMs through mass spectrometry is essential. This allows identification of phosphorylation, acetylation, ubiquitination, and other modifications that may regulate GET4 activity. Phosphoproteomic analysis has revealed several conserved phosphorylation sites that modulate GET4's interaction with binding partners .

  • Expression system selection impact: The choice between prokaryotic and eukaryotic expression systems creates fundamentally different PTM landscapes:

    • E. coli-expressed GET4 lacks glycosylation and most phosphorylation events

    • Mammalian cell-expressed GET4 exhibits more native-like modifications

    • Wheat germ-based systems provide intermediate modification patterns

  • Modification-specific functional assays: To determine how specific PTMs affect GET4 function, site-directed mutagenesis to create phosphomimetic (e.g., serine to glutamate) or phospho-null (serine to alanine) mutations provides valuable comparative data. These modified proteins can be tested in parallel for differences in:

    • Binding affinity to known partners like ASNA1

    • Subcellular localization patterns

    • Protein stability and turnover rates

  • Conditional modification control: Experimental designs should include conditions that promote or inhibit specific modifications. For instance, phosphatase inhibitors during protein purification preserve phosphorylation states, while expression in the presence of deacetylase inhibitors maintains acetylation levels .

These methodological approaches collectively enable researchers to distinguish between biologically relevant modifications and artifacts of the expression system, ensuring more accurate characterization of native GET4 function .

What genomic prediction methods are most effective for studying GET4-related traits in poultry breeding programs?

Genomic prediction methods for studying GET4-related traits in poultry require sophisticated statistical approaches that balance accuracy with computational efficiency. Based on comparative analyses, the single-step genomic best linear unbiased prediction (ssGBLUP) model has demonstrated superior performance over traditional pedigree-based methods for GET4-associated traits .

The methodological framework for effective genomic prediction includes:

  • Model selection strategy: The ssGBLUP model integrates genomic, pedigree, and phenotypic information simultaneously, achieving 4.3% to 16.4% higher prediction accuracy compared to pedigree-based BLUP (PBLUP) models. This integration is particularly valuable for studying complex GET4-influenced traits with moderate heritability .

  • SNP panel optimization: For GET4-specific studies, targeted SNP panels should include markers in linkage disequilibrium with GET4 regulatory regions. A minimum density of 50,000 genome-wide SNPs is recommended, though higher densities improve accuracy at increased computational cost .

  • Cross-validation protocol: Implementing k-fold cross-validation (typically k=5) with careful stratification of training and validation populations prevents overfitting and provides realistic accuracy estimates. Multiple validation schemes should test performance across different family structures .

  • Genomic relationship matrix construction: Several methods for constructing the genomic relationship matrix (G) affect prediction accuracy:

    • Method 1: VanRaden's first method using allele frequencies

    • Method 2: Standardized incidence matrices

    • Method 3: Adjusted matrices that account for breed-specific allele frequencies
      For GET4-related traits, Method 1 with population-specific allele frequencies typically yields optimal results .

  • Bayesian approach integration: For traits with known large-effect QTLs associated with GET4, Bayesian methods (BayesB or BayesC) may outperform GBLUP by allowing for non-normal distribution of marker effects. These methods assign different prior distributions to marker effects, accommodating the biological reality that some markers have substantially larger effects than others .

Implementation of these genomic prediction methodologies provides more accurate selection decisions for GET4-influenced traits while reducing generation intervals in poultry breeding programs .

How can transgenic chicken models be developed to study GET4 function using recombinase-mediated gene cassette exchange?

Developing transgenic chicken models for GET4 functional studies using recombinase-mediated gene cassette exchange (RMCE) requires a systematic approach combining molecular techniques with avian embryology. The following methodological framework outlines the critical steps:

  • Vector construction strategy: Design a donor vector containing FRT-flanked GET4 expression cassette with appropriate regulatory elements. The vector should include:

    • Chicken-optimized GET4 coding sequence

    • Suitable promoter (e.g., chicken β-actin promoter for ubiquitous expression)

    • Reporter gene (e.g., GFP) for visual confirmation of integration

    • FRT sites in direct orientation flanking the cassette

  • Primordial germ cell (PGC) isolation and culture: Isolate PGCs from stage 14-17 embryos using density gradient centrifugation. Maintain cells in specialized media containing fibroblast growth factor, stem cell factor, and leukemia inhibitory factor to preserve germline competence. This critical step ensures that genetic modifications will be transmitted to offspring .

  • PiggyBac-mediated transposition: Transfect PGCs with constructed vectors and piggyBac transposase to facilitate genomic integration. The piggyBac system provides several advantages for avian transgenesis:

    • Higher integration efficiency compared to conventional methods

    • Capacity for larger insert sizes (up to 100 kb)

    • Precise excision without leaving footprints in the genome

  • Integration verification protocol: Employ molecular characterization techniques including:

    • PCR-based genotyping for presence of integrated cassette

    • Southern blot analysis to determine copy number and integration patterns

    • Quantitative RT-PCR to assess expression levels in different tissues

  • Chimeric founder generation: Inject genetically modified PGCs into the bloodstream of recipient stage 14-16 embryos, where they migrate to and colonize the developing gonads. This technique produces chimeric birds carrying the genetic modification in their germline .

  • RMCE induction: Once transgenic lines are established, introduce Flp recombinase and a replacement cassette containing modified GET4 variants to facilitate RMCE. This step enables precise substitution of the original cassette with experimental variants without disrupting the genomic context .

This methodological approach has demonstrated successful integration patterns in transgenic chicken lines, with transgene expression levels varying across tissues based on integration sites. The RMCE system maintains expression of replaced gene cassettes in predominant FRT loci, enabling controlled study of GET4 variants without confounding epigenetic influences .

What are the most effective analytical approaches for identifying GET4-associated SNPs in genome-wide association studies?

Identifying GET4-associated SNPs through genome-wide association studies (GWAS) requires sophisticated analytical approaches that balance statistical power with false discovery control. The following methodological framework provides optimal detection of genuine GET4 associations:

  • Population structure correction: Employ principal component analysis (PCA) to identify and correct for population stratification. Include the first 3-5 principal components as covariates in the GWAS model to prevent spurious associations. Alternatively, implement a genomic relationship matrix to account for cryptic relatedness .

  • Multiple testing correction protocol: Apply appropriate multiple testing corrections to control false discovery rate (FDR):

    • Bonferroni correction for stringent control (p < 0.05/number of SNPs)

    • Benjamini-Hochberg procedure for moderate FDR control

    • q-value methodology for estimating proportion of true null hypotheses
      For GET4-related studies, significance thresholds typically range from 10^-5 to 10^-7 depending on effective number of independent tests .

  • Functional annotation pipeline: Prioritize statistically significant SNPs through functional annotation:

    • Identify missense variants with potential functional impact

    • Analyze regulatory regions affecting GET4 expression

    • Assess evolutionary conservation across species
      This approach has successfully identified missense SNPs with demonstrable effects on GET4-related phenotypes .

  • Regional association plotting: Implement regional visualization using tools like LocusZoom to examine linkage disequilibrium patterns around significant SNPs. This reveals whether multiple signals represent independent associations or a single causal variant .

  • Conditional analysis strategy: Perform conditional analyses by including top SNPs as covariates in subsequent GWAS models to distinguish independent signals from those in linkage disequilibrium. This approach has revealed distinct causal variants affecting GET4 function .

These methodological approaches have successfully identified multiple significant SNPs associated with GET4-related traits, including four missense variants that can be utilized for marker-assisted selection in breeding programs .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.